XML 28 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Compensation
9 Months Ended
Sep. 30, 2017
Stock Compensation [Abstract]  
Stock Compensation

13.  Stock Compensation 

 

Overview



We have stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (“RSAs”), performance stock awards (“PSAs”), restricted stock units (“RSUs”), performance stock units (“PSUs”), and options to purchase shares of our common stock at exercise prices generally equal to the fair value of such stock at the dates of grant.  We also maintain a shareholder-approved Employee Stock Purchase Plan (the “ESPP”) for the benefit of our employees.  The ESPP allows eligible employees to purchase common stock on a regular basis at the lower of 85% of the market price at the beginning or end of each offering period. 



Equity Grants

 

During the nine months ended September 30, 2017 the Compensation Committee of our Board of Directors (the “Committee”) authorized awards from approved stock incentive plans of RSUs to certain employees and RSAs and PSUs to certain Company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together totaled 384,000 shares and had an aggregate grant date market value of $6.3 million.  The PSUs granted in 2017 represent the right to receive from 60% to 150% of the target number of shares of common stock.  The performance component of PSU awards granted in 2017 is based on attaining specified levels of adjusted EBITDA, adjusted inventory levels, and trade accounts receivable days' sales outstanding, each as defined in the PSU grant documents, for the 2017 calendar year.  We currently believe that achievement of the performance component is probable, and we reevaluate this likelihood on a quarterly basis.    



During the nine months ended September 30, 2016 the Committee authorized awards from approved stock incentive plans of RSUs to certain employees and RSAs and PSUs to certain Company officers, which, including PSUs at target levels, together totaled 478,000 shares of common stock and had an aggregate grant date market value of $5.3 million.  The PSUs granted in 2016 represented the right to receive from 60% to 150% of the target number of shares of common stock.  The performance component of PSU awards granted in 2016 was based on attaining specified levels of adjusted EBITDA, adjusted inventory levels, and trade accounts receivable days sales outstanding, each as defined in the PSU grant documents, for the 2016 calendar year.  The PSUs granted in 2016 earned 142% of the target number of shares.



The Committee authorized, from approved stock incentive plans, grants of stock options to purchase a total of 260,000 and 387,000 shares to certain Company officers during the nine months ended September 30, 2017 and 2016, respectively.  The exercise prices of the options were equal to the closing stock prices on their respective grant dates.



Employees purchased common stock totaling 47,000 and 93,000 shares in the three and nine months ended September 30, 2017, respectively, and 52,000 and 90,000 shares in the three and nine months ended September 30, 2016, respectively, through the ESPP. 



Stock Compensation Expense 

 

The following weighted‑average assumptions were used to determine the fair value of options: 





 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Nine Months Ended



September 30, 2017

 

September 30, 2017



Stock Options

 

ESPP Options

 

Stock Options

 

ESPP Options

Expected life of options

 

N/A

 

 

0.5 Years

 

 

4.8 Years

 

 

0.5 Years

Expected stock price volatility

 

N/A

 

 

0.43 

 

 

0.40 

 

 

0.35 

Risk-free interest rate

 

N/A

 

 

1.14% 

 

 

1.87% 

 

 

0.62% 













 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Nine Months Ended



September 30, 2016

 

September 30, 2016



Stock Options

 

ESPP Options

 

Stock Options

 

ESPP Options

Expected life of options

 

4.8 Years

 

 

0.5 Years

 

 

4.8 Years

 

 

0.5 Years

Expected stock price volatility

 

0.40 

 

 

0.30 

 

 

0.40 

 

 

0.30 

Risk-free interest rate

 

1.19% 

 

 

0.49% 

 

 

1.20% 

 

 

0.49% 







 

The following table summarizes total stock compensation expenses prior to the capitalization of amounts into deferred preservation and inventory costs (in thousands): 





 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Nine Months Ended



September 30,

 

September 30,



2017

 

2016

 

2017

 

2016

RSA, PSA, RSU, and PSU expense

$

1,448 

 

$

1,397 

 

$

4,326 

 

$

3,616 

Stock option and ESPP option expense

 

519 

 

 

421 

 

 

1,614 

 

 

1,203 

Total stock compensation expense

$

1,967 

 

$

1,818 

 

$

5,940 

 

$

4,819 

  





Included in the total stock compensation expense, as applicable in each period, were expenses related to RSAs, PSAs, RSUs, PSUs, and stock options issued in each respective year, as well as those issued in prior periods that continue to vest during the period, and compensation related to the ESPP.  These amounts were recorded as stock compensation expense and were subject to our normal allocation of expenses to inventory costs and deferred preservation costs.  We capitalized $111,000 and $288,000 in the three and nine months ended September 30, 2017, respectively, and $70,000 and $202,000 in the three and nine months ended September 30, 2016, respectively, of the stock compensation expense into our inventory costs and deferred preservation costs.



As of September 30, 2017 we had total unrecognized compensation costs of $6.8 million related to RSUs, RSAs, and PSUs and $2.1 million related to unvested stock options.  As of September 30, 2017 this expense is expected to be recognized over a weighted-average period of 2.1 years for RSUs, 1.7 years for stock options, 1.3 years for RSAs, and 1.0 years for PSUs.